Lansoprazolo Zentiva

Lansoprazole, the active ingredient in Lansoprazolo Zentiva, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces gastric acid production and is used to manage conditions such as gastro‑esophageal reflux disease, peptic ulcer disease, and Helicobacter pylori infection in adults.

GNH USA supplies Lansoprazolo Zentiva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lansoprazolo Zentiva is a proton pump inhibitor indicated for several acid‑related gastrointestinal conditions.

- Gastro‑esophageal reflux disease (GERD): reduces reflux symptoms and promotes healing of esophageal irritation. - Peptic ulcer disease: facilitates ulcer healing by suppressing gastric acid. - NSAID‑induced gastric ulcer: protects the gastric mucosa during non‑steroidal anti‑inflammatory drug therapy. - Helicobacter pylori eradication (in combination therapy): enhances the effectiveness of antibiotic regimens by decreasing gastric acidity.

Lansoprazolo Zentiva may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: loose stools occurring during treatment. - Abdominal pain: discomfort or cramping in the stomach area. - Nausea: feeling of queasiness. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): swelling, rash, difficulty breathing. - Clostridioides difficile infection: severe diarrhea with possible colitis. - Hypomagnesemia: low magnesium levels with prolonged use. - Elevated liver enzymes: signs of hepatic stress. - Stevens‑Johnson syndrome: serious skin and mucous membrane disorder. - Interstitial nephritis: kidney inflammation presenting with reduced renal function.

Before initiating therapy with Lansoprazolo Zentiva, consider the following precautions.

- Assess renal function: adjust therapy in patients with severe impairment. - Monitor for infection: prolonged use may increase risk of C. difficile infection. - Check magnesium levels: long‑term therapy can cause hypomagnesemia. - Avoid in known hypersensitivity: discontinue if rash or angioedema develops. - Pregnancy and lactation: use only if potential benefit justifies the potential risk. - Store at ambient temperature: keep below 25°C, protect from moisture and retain in original packaging.

Lansoprazolo Zentiva can interact with several medicines, affecting their efficacy or safety.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, increasing cardiovascular risk. - Atazanavir: decreased absorption leading to subtherapeutic levels. - High‑dose methotrexate: increased toxicity due to reduced clearance.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR, requiring closer monitoring. - Digoxin: may raise serum digoxin concentrations. - Diazepam: potential increase in plasma levels, enhancing sedative effects.